

Monday: Biotech Analyst Rundown
The S&P 500 hit another all-time high last week as investors have become confident a Federal Reserve quarter point rate cut in on the near

Monday: Biotech Analyst Run Down
As we await a new trading week to open, here are four biotech stocks garnering positive analyst commentary today.

The Unvarnished Truth About Investing
In my over three decades of investing I have found there are two ways to beat the overall returns of the market over time.

Biotech Analyst Rundown
Thanks to the $11.4 billion buyout of Array Biopharma (ARRY) by Pfizer (PFE) yesterday, the biotech sector had one of its best days in...

4 Biotech Stocks With Analyst Focus Today
"Rights" are something made up by governments to make you feel like you're buying something with your taxes.” ― Stefan Molyneux Biotech...

4 Biotech Stocks Analysts Like Right Now
The people who are crazy enough to think they can change the world are the ones who do.” ― Rob Siltanen The S&P 500 and NASDAQ both hit...

Properly Managing And Optimizing A Biotech Portfolio
The biotech and biopharma space is probably the most volatile area of the market. It is a high risk/high reward arena for aggressive...







